GSK press releases Follow GSK to submit label update for Wellcovorin (leucovorin) at US FDA’s request GSK confirmed today that it will submit a supplemental New Drug Application (sNDA) for Wellcovorin (leucovorin) https://www.gsk.com/en-gb/media/press-releases/gsk-to-submit-label-update-for-wellcovorin-leucovorin-at-us-fda-s-request/ gsk.com
